MSF’s Khayelitsha programme was the first in South Africa to provide antiretroviral therapy (ART) in the public sector at the primary health care. It is also one of two pilot projects in the country to provide decentralized care for drug-resistant tuberculosis (DR-TB).
This report highlights the key clinical, programmatic, and policy changes that have supported universal coverage for HIV and TB care in Khayelitsha. It concludes by outlining, more generally, the future challenges and potential models for long-term ART care.
Khayelitsha Report 2008-2009
pdf — 1.76 MB